FDA institutes shortened approval pathway for biosimilarsThe FDA has enacted a shortened regulatory pathway for certain biologics, which will allow for faster approvals and increased competition. Avion introduces GloperbaAvion's Gloperba in a liquid oral solution is now available to treat gout. Camber launches generic Lyrica Camber's generic Lyrica is available in dosage strengths of 25, 50, 75, 100, 150, 200, 225, and 300 mg. Lupin launches generic Diprolene Betamethasone dipropionate ointment had a market value of approximately $21 million, according to IQVIA January 2020 data. Generic drug patent cases disrupted by COVID-19 The 30-month stay deadline surrounding generic drug patent disputes is being hampered by courts limiting access and attorneys cutting back on travel. Dr. Reddy's debuts generic Daraprim Daraprim (pyrimethamine) had a market value of approximately $10 million for the most recent 12 months ended January 2020, according to IQVIA. Pharma companies ramp up production of hydroxychloroquine to support COVID-19 response Several pharmaceutical companies are making a commitment to respond to COVID-19 by donating or accelerating the production of hydroxychloroquine. Dr. Reddy's launches pre-filled naloxone syringes Naloxone hydrochloride injection had a market value of roughly $31 million for the most recent 12 months ended January 2020, according to IQVIA. IQVIA report: Global medicine spending to top $1.1T by 2024 IQVIA reports that global use of medicine has increased at a 3% compound annual growth rate since 2014, slowing from a 4% rate from 2009–2014. Dr. Reddy's launches 1st generic of Geodon for injection The Geodon for injection brand had a market value of approximately $21.8 million for the most recent 12 months ended January 2020, according to IQVIA. First Previous 162 163 164 165 166 Next Last
